HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION explained in plain language.

Never miss a new study

Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION trials appear

Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a weekly pill replace daily HIV meds? new trial investigates

Disease control Ongoing

This study is testing if a new combination of two drugs (islatravir and ulonivirine), taken just once a week, can keep HIV under control as effectively as a standard daily pill regimen. It will involve about 150 adults whose HIV is already well-managed on daily medication. The ma…

Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION trials appear

Could a weekly pill replace daily HIV meds? new trial investigates